Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133569) titled 'A Randomized, Double-Blind, Placebo-Controlled Exploratory Clinical Study on High-Concentration Compound Lactic Acid Bacteria Metabolite JK-5G Promoting Gastrointestinal Function Recovery After Surgery for Cancerous Intestinal Obstruction' on Sept. 29.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital of Wenzhou Medical University
Condition:
Malignant bowel obstruction caused by primary colorectal malignant tumor
Intervention:
Intervention Group:Postbiotic Preparation JK5G (One sachet per dose, three times daily, for 10 days)
Recruitment Status: Not Recr...